Skip to main content

Table 3 Risk of Bias assessment of the studies by domain

From: The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies

Study type

NON-RANDOMIZED (125 studies)

Risk of bias, n (%)

CRITICAL

MODERATE

LOW

Domain

Confounding bias

119 (95)

6 (0.5)

0

Bias in selection of participants

110 (88)

15 (1.2)

0

Bias in classification of interventions

107 (86)

18 (14)

0

Deviation from intended interventions

92 (74)

32 (26)

1 (0.8)

Missing data

0

15 (12)

110 (88)

Bias in selection of reported results

0

10 (8)

115 (92)

Study type

RANDOMIZED (9 studies)

CRITICAL

MODERATE

LOW

Domain

Selection bias

2 (22)

5 (55)

2 (22)

Performance bias

2 (22)

6 (67)

1 (11)

Detection bias

3 (33)

5 (55)

1 (11)

Attrition bias

1 (11)

6 (67)

2 (22)

Reporting bias

0

2 (22)

7 (77)

Other bias

0

1 (1)

8 (6)